BIOPOL CHEMICALS LIMITED Intrinsic Value

BIOPOL · Chemicals · Current price ₹46.15

Full stock page
DocStoX fair value
₹167
low confidence
Current price
₹46
Upside to fair value
+261.7%
Verdict
Strong Buy
Quality score
5.7 / 10
Model it yourself — Intrinsic Value Calculator
Opens pre-filled with BIOPOL CHEMICALS LIMITED's latest numbers.

Is BIOPOL CHEMICALS LIMITED undervalued?

DocStoX estimates the fair value of BIOPOL CHEMICALS LIMITED at ₹167 per share, versus the current market price of ₹46. That puts the stock about +261.7% below our fair-value estimate, which we read as "Strong Buy". Our confidence in this estimate is low.

How this fair value is calculated

This estimate blends 3 independent methods: Residual income (₹73), Relative P/E (₹433), Graham floor (₹79). We weight each by its reliability and skip any method whose inputs look untrustworthy — "no DCF beats a wrong DCF". This is the same deterministic engine that powers DocStoX stock pages; there is no guesswork or AI-generated number here.

Bear, base and bull scenarios

Our scenarios span ₹73 (bear) to ₹167 (base) to ₹433 (bull). A margin of safety means buying meaningfully below the base case — the wider the gap, the more room for error in the assumptions.

Margin of safety

Value investors demand a margin of safety — a discount to intrinsic value that protects against being wrong. At ₹46 versus an intrinsic value of ₹167, BIOPOL CHEMICALS LIMITED currently offers +261.7% of margin.

More on BIOPOL CHEMICALS LIMITED

Fair ValueDCFValuationFinancial RatiosPeers

DocStoX estimates are generated by a deterministic valuation engine from reported financials — for informational purposes only, not investment advice. Consult a SEBI-registered advisor before investing.